Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.
about
The Many Faces of IpaBHuman anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague modelImmune defense against pneumonic plagueDirect neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrVAmino acid and structural variability of Yersinia pestis LcrV protein.Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseasesBiosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division.Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaquesTNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plagueIL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis.Development of in vitro correlate assays of immunity to infection with Yersinia pestis.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionDiminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.Early sensing of Yersinia pestis airway infection by bone marrow cells.Toward a molecular pathogenic pathway for Yersinia pestis YopM.Current challenges in the development of vaccines for pneumonic plague.Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte functionEffective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestisImmunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plagueCell-mediated defense against Yersinia pestis infection.High-throughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay.Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plagueSurface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.Prophylaxis and therapy of plague.Induction of type I interferon through a non-canonical Toll-like receptor 7 pathway during Yersinia pestis infectionFibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.Immunology of Yersinia pestis Infection.Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophagesAntibodies and cytokines independently protect against pneumonic plague.
P2860
Q26767237-D4891A6B-332B-4594-8A26-A1FE08902844Q28748886-5B503CE1-FF8C-41E3-B381-A7B6CCFCBC19Q33584403-D9B11D1F-6859-4601-85F4-52E12FF5B386Q33601814-F1CC6843-B002-472D-BD8A-4E9A761F2ECAQ33636983-BF7A36BA-76D8-43C5-B17F-402979F4886FQ33847904-781D16AE-5394-44A0-9F1D-657EA15B05ACQ34045080-39D29879-08E8-416F-B13A-1E34C2FA10A9Q34119457-465B257A-E43E-4340-90F5-BF20AC634080Q34290878-41B6C32A-FE39-4038-92B8-DDCEA70F013EQ34380204-0454698A-D878-470B-80E1-C20404827DB7Q34760779-32152039-32BF-489E-9743-097CEBAC202FQ34786724-B415D855-F968-44E3-9939-80D97310576CQ35671617-BD21024A-2F96-4AF5-9691-3A9EA9AD4502Q35783560-F3B023DC-547C-483A-A5F7-D5B9EFA97836Q36238031-DF43E65F-2045-4045-BFBB-D3E54CF31110Q36315321-50DBC2B6-6726-4195-9080-9FE93E8C7EC8Q36421830-6E5CDAD5-E90C-4319-B83D-69827A281DF5Q36457572-4085889D-3C5E-4EE1-936C-58FBEB2A8D1BQ36628038-086263C5-45AD-41EF-B21E-4120007226B3Q36804172-00045416-C262-4F50-AD8E-14E3D13BEB34Q36804213-843545F9-327E-44A0-A6A5-B1A185A9D4CDQ36950063-5B3F6B25-B4BF-4E9D-8C3C-683763FB16B1Q36974485-E872D89E-6D77-4034-B0B4-646F4E0E4EF5Q36984064-B0FA327F-6CE4-4EEA-9840-F6B99B82ED01Q37355871-9B792A6B-A347-4EDE-955A-117D16559FCDQ37450884-FB7BB4AD-5BB4-498C-BB06-9970E4519E43Q38006509-B5AC601D-663E-49DA-821D-34BAEEF21491Q38131537-A7107C65-F1D8-4397-8D58-23465615068EQ38605193-74255B26-320E-4D31-A1D5-7C65501D6F36Q39736724-5C3CCEED-6FD8-4DAB-B2FE-29C651292E4DQ40512106-2504E54C-B233-4149-ABE0-6E1D9EBA808DQ41437577-7F7D347D-1034-46B5-A4D3-D8F353DBC6F5Q41441607-2A8812B3-CB82-4530-AC68-BF6043355D99
P2860
Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@ast
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@en
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@nl
type
label
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@ast
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@en
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@nl
prefLabel
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@ast
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@en
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@nl
P2093
P2860
P921
P1476
Anti-LcrV antibody inhibits de ...... rectly promoting phagocytosis.
@en
P2093
Alexander V Philipovskiy
Christine R Wulff-Strobel
Clarissa Cowan
Susan C Straley
P2860
P304
P356
10.1128/IAI.73.9.6127-6137.2005
P407
P577
2005-09-01T00:00:00Z